Holen Sie sich die Stockscreener-App
31.32
3.09%
-1.00
Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? - Zacks Investment Research
4 High-Risk Stocks Built for Big Returns - The Motley Fool
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know - TradingView
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know - Zacks Investment Research
Agios' Growth Story Hinges on Mitapivat's Commercial Expansion - Zacks Investment Research
Agios' Growth Story Hinges on Mitapivat's Commercial Expansion - Yahoo Finance
Agios Pharmaceuticals, Inc. (AGIO) Investor Outlook: A 36% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
AGIO Maintained by B of A Securities -- Price Target Raised to $50 - GuruFocus
AGIOS PHARMACEUTICALS, INC. : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $50 FROM $46 - Bitget
Agios Pharmaceuticals Stock (AGIO) Opinions on Trading Strategies - Quiver Quantitative
Avoiding Lag: Real-Time Signals in (AGIO) Movement - Stock Traders Daily
Bank of America Corp DE Sells 31,441 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Agios Pharmaceuticals: Indication Stacking Is Creating A Commercial Flywheel (NASDAQ:AGIO) - Seeking Alpha
We're Not Very Worried About Agios Pharmaceuticals' (NASDAQ:AGIO) Cash Burn Rate - Moomoo
Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes - Sahm
612,850 Shares in Agios Pharmaceuticals, Inc. $AGIO Acquired by SCS Capital Management LLC - MarketBeat
Assenagon Asset Management S.A. Has $3.86 Million Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Agios Pharmaceuticals, Inc. (AGIO) And Encourages Shareholders to Reach Out - ACCESS Newswire
Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO) - The Globe and Mail
Q4 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Agios Pharmaceuticals, Inc. (AGIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Agios Pharmaceuticals (AGIO) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Agios Pharmaceuticals, Inc. (AGIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sei Investments Co. Acquires 49,198 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Responsive Playbooks and the AGIO Inflection - Stock Traders Daily
FARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals In - GuruFocus
Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - Sahm
AGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocus
Agios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to $34.00 at JPMorgan Chase & Co. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Agios Pharmaceuticals, Inc. (AGIO) And Encourages Investors to Connect - ACCESS Newswire
Agios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Agios Pharmaceuticals, Inc. (AGIO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 30,000 Shares - MarketBeat
Agios Pharmaceuticals (AGIO) CMO sells 30,000 shares in plan trade - Stock Titan
How Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - simplywall.st
How Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - webull.com
AGIO (NASDAQ: AGIO) insider Sarah Gheuens files to sell 30,000 shares - stocktitan.net
Dimensional Fund Advisors LP Increases Position in Agios Pharmaceuticals, Inc. $AGIO - marketbeat.com
Agios Pharmaceuticals (AGIO) Stock Analysis: High Potential Upside In The Biotech Sector - DirectorsTalk Interviews
Farallon Capital (AGIO) discloses 5.9M-share, 9.9% position in Agios - Stock Titan
Seven Fleet Capital Management LP Has $7.09 Million Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Arrowstreet Capital Limited Partnership Makes New Investment in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Agios Pharmaceuticals, Inc. (AGIO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Price to sales forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO - TradingView
Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39 - Moomoo
A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55 - Moomoo
AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year - Yahoo Finance
AGIO: Q2 2026 delivered $44.7M revenue, strong AQVESME launch, and pipeline progress with ~$1B cash - TradingView
16.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):